Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jul;15(3):192-197.
doi: 10.1007/s13181-019-00706-1. Epub 2019 Mar 22.

Ten Years of Robotripping: Evidence of Tolerance to Dextromethorphan Hydrobromide in a Long-Term User

Affiliations
Case Reports

Ten Years of Robotripping: Evidence of Tolerance to Dextromethorphan Hydrobromide in a Long-Term User

Travis D Olives et al. J Med Toxicol. 2019 Jul.

Abstract

Introduction: Dextromethorphan hydrobromide is widely available as an over-the-counter cough suppressant. A semi-synthetic opioid displaying N-methyl-D-aspartate receptor antagonism, it is commonly abused for recreational purposes. Spuriously elevated serum chloride concentrations are a well-described phenomenon in the setting of dextromethorphan hydrobromide toxicity, but evidence to suggest the development of tolerance is limited to case reports.

Case: A 32-year-old male known to chronically ingest dextromethorphan hydrobromide for recreational purposes presented to regional hospitals on 179 occasions over 110 months and was treated for dextromethorphan toxicity on 163/174 (93.7%) of these visits. He reported a subjective need to increase his dosing over time to achieve the same degree of intoxication. Measured serum chloride over this period (n = 217) ranged from 98 to 138 mEq/L (median 115 mEq/L, IQR 110-123 mEq/L). Measured concentrations over the 110-month period progressively rose, with a fitted plot of 111.15 + 0.00232x describing the rise in measured chloride. Though not formally assessed, anion gaps tended to become progressively more negative over the observed period.

Discussion: We report a patient with persistent dextromethorphan hydrobromide abuse at escalating doses whose mean serum chloride concentration increased, on average, by 0.00232 mEq/L every day over a 110-month period. This case demonstrates progressive spurious hyperchloremia secondary to bromide interference in hospital-based chloride assays, supporting the patient's reported need to dose escalate to the same desired effect. Although this artefactual laboratory finding is a well-documented result of bromide ingestion, it may be useful in identifying patterns of dextromethorphan hydrobromide use that suggest tolerance.

Keywords: Bromism; Dextromethorphan; Hyperchloremia; Robotripping; Tolerance.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Median serum chloride by hospitalization day
Fig. 2
Fig. 2
Distribution of serum chloride concentrations
Fig. 3
Fig. 3
a All serum chloride concentration over time. b Presenting serum chloride concentrations over time
Fig. 3
Fig. 3
a All serum chloride concentration over time. b Presenting serum chloride concentrations over time

Similar articles

References

    1. Boyer EW. Dextromethorphan abuse. Pediatr Emerg Care. 2004;20(12):858–863. doi: 10.1097/01.pec.0000148039.14588.d0. - DOI - PubMed
    1. Romanelli F, Smith KM. Dextromethorphan abuse: clinical effects and management. J Am Pharm Assoc. 2009;49(2):e20–e27. doi: 10.1331/JAPhA.2009.08091. - DOI - PubMed
    1. Spangler DC, Loyd CM, Skor EE. Dextromethorphan: a case study on addressing abuse of a safe and effective drug. Subst Abus Treat Prev Policy. 2016;11(1):1–7. doi: 10.1186/s13011-015-0046-x. - DOI - PMC - PubMed
    1. Storck M, Black L, Liddell M. Inhalant abuse and dextromethorphan. Child Adolesc Psychiatr Clin N Am. 2016;25(3):497–508. doi: 10.1016/j.chc.2016.03.007. - DOI - PubMed
    1. Wilson MD, Ferguson RW, Mazer ME, Litovitz TL. Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000-2010. Clin Toxicol. 2011;49(5):409–415. doi: 10.3109/15563650.2011.585429. - DOI - PubMed

Publication types